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SUMMARY
Extramedullary plasmacytomas (EP) are tumours
composed by a monoclonal population of plasma cells
that arise in extraosseus tissues, comprising <5% of all
plasma cell neoplasms. Usually, EP arise in the head and
neck region, and the stomach is the second most
common location—gastric plasmacytoma (GP). Clinical
and radiological manifestations are unspeciﬁc and may
mimic other tumours like gastric adenocarcinomas,
gastric stromal tumours and lymphomas, mainly marginal
cell lymphoma (MALT lymphoma) and usually deﬁnitive
diagnosis is provided by pathological evaluation. We
present a case of primary GP, discovered incidentally as
a polypoid lesion. Tumour was composed by sheets of
mature and immature plasmocytes positive for CD138 on
immunohistochemistry, without Helicobacter pylori
identiﬁcation. The patient is alive 6 years later and
without tumour relapse.
BACKGROUND
This case was written due to its rarity and in order
to increase awareness of the entity. Gastric plasma-
cytomas (GP) are very rare but with good prognosis,
with non-speciﬁc clinical and radiological presenta-
tions that may mislead the clinician into a diagnosis
of a more aggressive tumour. Pathological examin-
ation usually provides the diagnosis, but sometimes
it may not be obvious and extensive immunohisto-
chemistry panel has to be employed as in our case.
Knowledge of GP characteristics might improve
disease approach with quick and accurate diagnosis.
CASE PRESENTATION
A man aged 61 years recurs to the emergency
department with symptoms of upper gastrointes-
tinal bleeding.
Personal background included tongue carcinoma
surgically removed 4 years before, alcoholic cirrho-
sis, type II diabetes mellitus, arterial hypertension,
atrial ﬁbrillation, congestive heart failure, chronic
gastritis, obesity and prostate benign hyperplasia.
Familiar background revealed grandmother with
breast cancer and aunt with head and neck cancer.
Regular medication was pantoprazole, warfarin,
amiodarone, spironolactone, furosemide, insulin,
metformin, candesartan, digoxin and ﬁnasteride.
INVESTIGATIONS
An upper endoscopy was promptly performed and
showed a 40 mm gastric lobulated sessile polypoid
lesion (type 0-Is, Paris classiﬁcation) on the greater
curvature of the distal body, lined by mucosa with
ulcerated areas (ﬁgure 1). Patient status and
characteristics of the lesion allowed endoscopic
intervention, and a piecemeal endoscopic mucosal
resection (inject and cut technique) was performed.
The procedure underwent uneventfully.
Histological examination was performed on
H&E-stained slides observed in light microscope—
Nikon Eclipse 50i, and images obtained using a
Nikon-Digital Sight DS-Fi1 camera.
The endoscopic mucosectomy fractioned speci-
men was composed of three fragments, the larger
with polypoid conﬁguration measuring 2.5 cm.
Externally, it had a dark brown rough surface and
on cut section showed a brownish tissue with white
ﬁrm areas.
Histologically, the bigger fragment revealed in
the lamina propria (ﬁgure 2A) a dense proliferation
forming a cohesive sheet of medium and large cells
(ﬁgure 2B) with eosinophil cytoplasm of undeﬁned
boundaries and pleomorphic nuclei with grumpy
chromatin. In some areas, it was possible to identify
mature and immature plasmocytes. No lymphoe-
pithelial lesions were seen. Mitotic activity was fre-
quent (26 mitoses/10 high-power-ﬁelds) (ﬁgure 2C,
D). The lesion had a polypoid growth, partially
ulcerated and covered by granulation tissue, and
showed in the periphery hyperplastic gastric
mucosa. The margin did not show signs of involve-
ment by the lesion and the remaining two frag-
ments were composed of normal oxyntic gastric
mucosa. Helicobacter pylori infection was ruled out
by Whartin Starry stain.
DIFFERENTIAL DIAGNOSIS
The lesion architecture and morphology were
unspeciﬁc and a ﬁrst panel of immunohistochemis-
try was performed on the basis of a ﬁrst approach
to diagnosis: lymphoma seemed more probable,
followed by carcinoma and melanoma or, in lower
probability, neuroendocrine carcinoma.
Immunohistochemical studies were performed on
one representative block of the lesion, resorting to
Figure 1 Endoscopy showed polypoid lesion on the
greater gastric curvature, with ulceration.
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avidin-biotin-peroxidase complex detection system and per-
formed on Ventana Marker Platform Bench Mark ULTRA
IHC/ISH using the following antibodies: AE1/AE3 (PCK26,
Ventana, Arizona, USA), Bcl-2 (124, Ventana), Bcl-6 (GI191E/
A8, CellMarque, California, USA), CD3 (2VG6, Ventana), CD5
(SP19, Ventana), CD10 (SP67, Ventana), CD20 (L26, Dako,
Denmark), CD43 (cL60, Ventana),CD45/LCA (2B11&PD7/26,
Ventana), CD79a (SP18, Ventana), CD138 (BA-38,
CellMarque), chromogranin A (LK2H10, Ventana), cyclinD1
(SP4-R, Ventana), epithelial membrane antigen (EMA,E29,
Ventana), IgA (polyclonal, CellMarque), IgG (polyclonal,
CellMarque), IgM (polyclonal, CellMarque), Ki67 (30-9,
Ventana), Kappa chain (polyclonal, Ventana), Lambda chain
(polyclonal, Ventana), LMP1 (CS1-4, CellMarque), PAX5
(SP34, Ventana), melanoma A (A103, Ventana), melanosome
(HMB45, Ventana), MUM1 (MRQ-43, CellMarque), myeolo-
peroxidase (polyclonal, CellMarque), synaptophysin (MRQ-40,
CellMarque), S100 protein (S100, 4C4.9, Ventana) and vimen-
tin (V9, Ventana).
The initial study was negative for AE1/AE3 (ﬁgure 3A),
CD45 (ﬁgure 3B), Melan A, HMB45, S100, chromogranin A
and synatophysine; positivity for vimentin was registered.
Incorporating the results with tumour morphology, we
thought of plasmablastic lymphoma, plasmacytoma/multiple
myeloma, MALT lymphoma with marked plasmacytic differenti-
ation and Castleman’s disease, plasma cell type.
A second panel of immunohistochemistry was negative for
CD20, CD79a, Bcl6, PAX5, CD3, CD5, CD10, cyclinD1 and
LMP1; Bcl2 and CD43 were positive and the Ki67 proliferative
index was near 60%.
Figure 2 H&E examination revealed
a dense proliferation in the lamina
propria (A, ×40) forming a cohesive
sheet of medium to large cells (B,
×100) with eosinophil cytoplasm of
undeﬁned boundaries and pleomorphic
nuclei with mitotic activity (C, ×400)
and mature and immature plasmocytes
(D, ×400).
Figure 3 Immunohistochemistry was
negative for AE1/AE3 (A) and for LCA
(B), with positivity for CD138 (C) and
Lambda chains (D).
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Rethinking our possibilities and once again conjugating with
morphology, especially taking into account the presence of
mature and immature plasmocytes in the periphery, the possibil-
ity of plasmacytoma/multiple myeloma was considered and on a
third immunohistochemical panel, we obtained positivity for
CD138 (ﬁgure 3C), EMA and MUM1; there was evidence of
lambda chain restriction (ﬁgure 3D), demonstrating a clonal
population. A diagnosis of GP/involvement by multiple
myeloma was made. The differential diagnosis between these
entities needs extra workup, namely bone marrow biopsy to
evaluate for plasma cell, assessment of plasmacystic skeletal
lesions, tumour serological markers and immunoglobulins as
well as protein electrophoresis.
Laboratory exams did not show any alterations, despite mild
anaemia. Tumour serological markers were normal as well as
immunoglobulins. Protein electrophoresis was normal and bone
marrow biopsy showed no involvement.
TREATMENT
Treatment consisted of endoscopic polypectomy without radi-
ation. Since no H. pylori was identiﬁed, eradication was not
performed.
OUTCOME AND FOLLOW-UP
The patient was discharged with no further therapeutic. One
year after polypectomy, prostate cancer was diagnosis by serum
PSA elevation—prostate biopsy showed Gleason 6 (3+3) adeno-
carcinoma—and treated with radiotherapy.
Currently, the patient is alive and has been on clinical
follow-up for 6 years, without signs of plasmacytic tumour
relapse.
DISCUSSION
Plasma cell neoplasms are deﬁned as mature B-cell neoplasm
according to the World Health Classiﬁcation1 and may divided
into four categories: multiple myeloma, plasma cell leukaemias,
solitary plasmacytomas of the bone and extramedullary plasma-
cytomas (EP); the latter are tumours composed by a monoclonal
and localised proliferation of plasma cells that arise in extraos-
seus tissues.2
EP are rare, comprising <5% of all plasma cell neoplasms
and normally presents as localised lesions, usually in the head
and neck region, being the stomach the second more common
location—GP.3
Biologically, GP seem distinct from their bone counterpart
and plasma cell myeloma and some authors believe that there is
an association with marginal zone lymphoma and H. pylori
infection.4
Clinically, GP are more frequent in men, with a median age
of 55 years,2 3 but some rare cases have been described in ado-
lescents;5 symptoms are usually non-speciﬁc and include weight
loss, epigastric pain/discomfort or gastrointestinal bleeding.6
Radiology is also vague in diagnosing GP, showing a polypoid
lesion or homogeneous concentric gastric wall thickening in
computerised tomography, generally interpreted as gastrointes-
tinal stromal tumour or lymphoma; due to mucosal/submucosal
origin of GP endoscopy may only show a protruding gastric wall
and be misjudged as adenocarcinoma,7 but represents a good
approach since allows tissue biopsy/tumour excision—essential
for diagnosis,4 as in our case—the tumour presented as sessile
polypoid lesion, which enable endoscopic mucosectomy.
The tumour morphology, with sheets of mature and immature
plasmocytes in the lamina propria, with high mitotic count and
absence of lymphoepithelial lesions raised as main differential
diagnosis: GP, MALT lymphoma with marked plasmacytic differ-
entiation, Castleman disease plasma cell variant, plasmablastic
lymphoma and diffuse large B-cell lymphoma anaplastic variant,
but the morphological ﬁndings associated with a correct immu-
nohistochemistry panel (CD20, CD79a, CD10, Bcl-2 negatives;
CD138, EMA, MUM1 positives and lambda chain restriction)
provided the correct diagnosis.2 3
However, pathology diagnosis, despite accurate for assessing a
monoclonal proliferation of plasma cells, is not synonym of GP,
since extramedullary involvement by multiple myeloma may
occur in up to 20% of the patients, and GP may be the initial
manifestation of a multiple myeloma, with some reports in the
literature.8 9
Therefore, the patient must undergo systemic evaluation to
exclude bone marrow involvement and there must not be clin-
ical or laboratory evidence of myeloma—low or absent
M-protein concentration, no hypercalcaemia and absence of
kidney failure.2 3 7 Our patient fulﬁlled all these criteria—it had
not bone marrow involvement, no plasmacytic bone lesions and
serological markers and protein electrophoresis were normal.
Similar to other gastric tumours like gastric adenocarcinoma
and MALT lymphoma, a putative relation with H. pylori has
been postulated, especially in cases with concomitant infection;
however, some GP cases did not have H. pylori infection;
despite there is not a deﬁnitive association, H. pylori eradication
may be considered as therapeutic option in these cases.10 11 In
the reported case, H. pylori was not present, so eradication was
not performed.
Surgery, with or without radiation, is the treatment of choice,
normally with good results.2 3 Follow-up usually is favourable,
with good disease-free survival at 10 years.6
Learning points
▸ Gastric plasmacytoma are rare entities comprising about 5%
of all plasma cell neoplasms.
▸ Final diagnosis is provided by pathological examination,
after extensive differential of hypothesis, supported by
immunohistochemistry.
▸ Multiple myeloma must be excluded with bone biopsy and
clinical/laboratory tests.
▸ Surgical excision normally is the treatment of choice, with
good results.
▸ Follow-up is favourable with long disease-free survival.
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